Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis

被引:631
作者
Bhatt, Deepak L. [1 ,3 ,4 ]
Eagle, Kim A. [6 ]
Ohman, E. Magnus [12 ]
Hirsch, Alan T. [8 ]
Goto, Shinya [7 ]
Mahoney, Elizabeth M.
Wilson, Peter W. F. [16 ]
Alberts, Mark J. [2 ]
D'Agostino, Ralph [5 ]
Liau, Chiau-Suong [9 ,10 ]
Mas, Jean-Louis [11 ]
Roether, Joachim [13 ]
Smith, Sidney C., Jr. [14 ]
Salette, Genevieve
Contant, Charles F.
Massaro, Joseph M.
Steg, Ph. Gabriel [15 ]
机构
[1] VA Boston Healthcare Syst, Boston, MA 02132 USA
[2] Northwestern Univ, Sch Med, Chicago, IL USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Boston Univ, Boston, MA 02215 USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
[7] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan
[8] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA
[9] Taiwan Univ Hosp, Taipei, Taiwan
[10] Coll Med, Taipei, Taiwan
[11] Ctr Raymond Garcin, Paris, France
[12] Duke Univ, Med Ctr, Durham, NC USA
[13] Asklepios Klin Altona, Dept Neurol, Hamburg, Germany
[14] Univ N Carolina, Chapel Hill, NC USA
[15] Hop Bichat Claude Bernard, F-75877 Paris 18, France
[16] Emory Univ, Sch Med, Atlanta, GA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2010年 / 304卷 / 12期
基金
美国国家卫生研究院;
关键词
ACUTE CORONARY SYNDROME; DISEASE; ROSIGLITAZONE; CLOPIDOGREL; PREVENTION; REDUCTION; CANGRELOR; MORTALITY; OUTCOMES; ASPIRIN;
D O I
10.1001/jama.2010.1322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Clinicians and trialists have difficulty with identifying which patients are highest risk for cardiovascular events. Prior ischemic events, polyvascular disease, and diabetes mellitus have all been identified as predictors of ischemic events, but their comparative contributions to future risk remain unclear. Objective To categorize the risk of cardiovascular events in stable outpatients with various initial manifestations of atherothrombosis using simple clinical descriptors. Design, Setting, and Patients Outpatients with coronary artery disease, cerebrovascular disease, or peripheral arterial disease or with multiple risk factors for atherothrombosis were enrolled in the global Reduction of Atherothrombosis for Continued Health (REACH) Registry and were followed up for as long as 4 years. Patients from 3647 centers in 29 countries were enrolled between 2003 and 2004 and followed up until 2008. Final database lock was in April 2009. Main Outcome Measures Rates of cardiovascular death, myocardial infarction, and stroke. Results A total of 45 227 patients with baseline data were included in this 4-year analysis. During the follow-up period, a total of 5481 patients experienced at least 1 event, including 2315 with cardiovascular death, 1228 with myocardial infarction, 1898 with stroke, and 40 with both a myocardial infarction and stroke on the same day. Among patients with atherothrombosis, those with a prior history of ischemic events at baseline (n=21 890) had the highest rate of subsequent ischemic events (18.3%; 95% confidence interval [CI], 17.4%-19.1%); patients with stable coronary, cerebrovascular, or peripheral artery disease (n=15 264) had a lower risk (12.2%; 95% CI, 11.4%-12.9%); and patients without established atherothrombosis but with risk factors only (n=8073) had the lowest risk (9.1%; 95% CI, 8.3%-9.9%) (P<.001 for all comparisons). In addition, in multivariable modeling, the presence of diabetes (hazard ratio [HR], 1.44; 95% CI, 1.36-1.53; P<.001), an ischemic event in the previous year (HR, 1.71; 95% CI, 1.57-1.85; P<.001), and polyvascular disease (HR, 1.99; 95% CI, 1.78-2.24; P<.001) each were associated with a significantly higher risk of the primary end point. Conclusion Clinical descriptors can assist clinicians in identifying high-risk patients within the broad range of risk for outpatients with atherothrombosis. JAMA. 2010; 304(12): 1350-1357
引用
收藏
页码:1350 / 1357
页数:8
相关论文
共 23 条
[11]   Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis [J].
Fonarow, GC ;
Adams, KF ;
Abraham, WT ;
Yancy, CW ;
Boscardin, WJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (05) :572-580
[12]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[13]   Platelet Inhibition with Cangrelor in Patients Undergoing PCI. [J].
Harrington, Robert A. ;
Stone, Gregg W. ;
McNulty, Steven ;
White, Harvey D. ;
Lincoff, A. Michael ;
Gibson, C. Michael ;
Pollack, Charles V., Jr. ;
Montalescot, Gilles ;
Mahaffey, Kenneth W. ;
Kleiman, Neal S. ;
Goodman, Shaun G. ;
Amine, Maged ;
Angiolillo, Dominick J. ;
Becker, Richard C. ;
Chew, Derek P. ;
French, William J. ;
Leisch, Franz ;
Parikh, Keyur H. ;
Skerjanec, Simona ;
Bhatt, Deepak L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (24) :2318-2329
[14]   Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis [J].
Home, Philip D. ;
Pocock, Stuart J. ;
Beck-Nielsen, Henning ;
Gomis, Ramon ;
Hanefeld, Markolf ;
Jones, Nigel P. ;
Komajda, Michel ;
McMurray, John J. V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :28-38
[15]   Cardiovascular Event Rates in Diabetic and Nondiabetic Individuals With and Without Established Atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry) [J].
Krempf, Michel ;
Parhofer, Klaus G. ;
Steg, Gabriel ;
Bhatt, Deepak L. ;
Ohman, Magnus ;
Roether, Joachim ;
Goto, Shinya ;
Pasquet, Blandine ;
Wilson, Peter W. F. .
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (05) :667-671
[16]   One-Year Costs in Patients With a History of or at Risk for Atherothrombosis in the United States [J].
Mahoney, Elizabeth M. ;
Wang, Kaijun ;
Cohen, David J. ;
Hirsch, Alan T. ;
Alberts, Mark J. ;
Eagle, Kim ;
Mosse, Frederique ;
Jackson, Joseph D. ;
Steg, P. Gabriel ;
Bhatt, Deepak L. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2008, 1 (01) :38-U68
[17]   Optimizing Trial Design Sequential, Adaptive, and Enrichment Strategies [J].
Mehta, Cyrus ;
Gao, Ping ;
Bhatt, Deepak L. ;
Harrington, Robert A. ;
Skerjanec, Simona ;
Ware, James H. .
CIRCULATION, 2009, 119 (04) :597-U199
[18]  
Müller-Riemenschneider F, 2010, ARCH INTERN MED, V170, P719, DOI 10.1001/archinternmed.2010.66
[19]   The REduction of Atherothrombosis for Continued Health (REACH) Registry:: An international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design [J].
Ohman, EM ;
Bhatt, DL ;
Steg, G ;
Goto, S ;
Hirsch, AT ;
Liau, CS ;
Mas, JL ;
Richard, AJ ;
Röther, J ;
Wilson, PWF .
AMERICAN HEART JOURNAL, 2006, 151 (04) :786.e1-786.e10
[20]   Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke [J].
Sacco, Ralph L. ;
Diener, Hans-Christoph ;
Yusuf, Salim ;
Cotton, Daniel ;
Ounpuu, Stephanie ;
Lawton, William A. ;
Palesch, Yuko ;
Martin, Renee H. ;
Albers, Gregory W. ;
Bath, Philip ;
Bornstein, Natan ;
Chan, Bernard P. L. ;
Chen, Sien-Tsong ;
Cunha, Luis ;
Dahlof, Bjorn ;
De Keyser, Jacques ;
Donnan, Geoffrey A. ;
Estol, Conrado ;
Gorelick, Philip ;
Gu, Vivian ;
Hermansson, Karin ;
Hilbrich, Lutz ;
Kaste, Markku ;
Lu, Chuanzhen ;
Machnig, Thomas ;
Pais, Prem ;
Roberts, Robin ;
Skvortsova, Veronika ;
Teal, Philip ;
Toni, Danilo ;
VanderMaelen, Cam ;
Voigt, Thor ;
Weber, Michael ;
Yoon, Byung-Woo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (12) :1238-1251